GENZYME CORPORATION

Company

BIOMARIN PHARMACEUTICAL INC

Filed

July 29, 1999

Accession Number

0000950135-99-003670

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →